CA2331041A1 - Reduced particle size form of 1-(6-chloronaphth-2-ylsulphonyl)-4-¬4-(4pyridyl)benzoyl|piperazine - Google Patents

Reduced particle size form of 1-(6-chloronaphth-2-ylsulphonyl)-4-¬4-(4pyridyl)benzoyl|piperazine Download PDF

Info

Publication number
CA2331041A1
CA2331041A1 CA002331041A CA2331041A CA2331041A1 CA 2331041 A1 CA2331041 A1 CA 2331041A1 CA 002331041 A CA002331041 A CA 002331041A CA 2331041 A CA2331041 A CA 2331041A CA 2331041 A1 CA2331041 A1 CA 2331041A1
Authority
CA
Canada
Prior art keywords
chloronaphth
ylsulphonyl
benzoyl
piperazine
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002331041A
Other languages
English (en)
French (fr)
Inventor
Roger James
Marianne Ashford
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2331041A1 publication Critical patent/CA2331041A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
CA002331041A 1998-05-02 1999-04-27 Reduced particle size form of 1-(6-chloronaphth-2-ylsulphonyl)-4-¬4-(4pyridyl)benzoyl|piperazine Abandoned CA2331041A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9809350.3 1998-05-02
GBGB9809350.3A GB9809350D0 (en) 1998-05-02 1998-05-02 Novel salt
PCT/GB1999/001316 WO1999057112A1 (en) 1998-05-02 1999-04-27 Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) -4-[4-(4pyridyl) benzoyl] piperazine

Publications (1)

Publication Number Publication Date
CA2331041A1 true CA2331041A1 (en) 1999-11-11

Family

ID=10831311

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002331041A Abandoned CA2331041A1 (en) 1998-05-02 1999-04-27 Reduced particle size form of 1-(6-chloronaphth-2-ylsulphonyl)-4-¬4-(4pyridyl)benzoyl|piperazine

Country Status (16)

Country Link
EP (1) EP1084118A1 (ja)
JP (1) JP2002513789A (ja)
KR (1) KR20010043216A (ja)
CN (1) CN1308629A (ja)
AU (1) AU3719699A (ja)
BR (1) BR9910176A (ja)
CA (1) CA2331041A1 (ja)
EE (1) EE200000638A (ja)
GB (1) GB9809350D0 (ja)
HU (1) HUP0102394A3 (ja)
IL (1) IL139405A0 (ja)
NO (1) NO20005498D0 (ja)
PL (1) PL343705A1 (ja)
SK (1) SK16522000A3 (ja)
WO (1) WO1999057112A1 (ja)
ZA (1) ZA200006036B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69833036T2 (de) * 1997-09-30 2006-06-22 Daiichi Pharmaceutical Co., Ltd. Sulfonylderivate
TWI290136B (en) 2000-04-05 2007-11-21 Daiichi Seiyaku Co Ethylenediamine derivatives
WO2003000657A1 (fr) 2001-06-20 2003-01-03 Daiichi Pharmaceutical Co., Ltd. Derives de diamine
DK1569912T3 (en) 2002-12-03 2015-06-29 Pharmacyclics Inc 2- (2-hydroxybiphenyl-3-yl) -1h-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA56197C2 (uk) * 1996-11-08 2003-05-15 Зенека Лімітед Гетероциклічні похідні
ATE334975T1 (de) * 1997-05-30 2006-08-15 Takeda Pharmaceutical Sulfonamidderivate, ihre herstellung und verwendung
DE69833036T2 (de) * 1997-09-30 2006-06-22 Daiichi Pharmaceutical Co., Ltd. Sulfonylderivate

Also Published As

Publication number Publication date
SK16522000A3 (sk) 2001-05-10
WO1999057112A1 (en) 1999-11-11
EE200000638A (et) 2002-04-15
HUP0102394A2 (hu) 2001-12-28
HUP0102394A3 (en) 2003-01-28
ZA200006036B (en) 2002-01-25
IL139405A0 (en) 2001-11-25
NO20005498L (no) 2000-11-01
JP2002513789A (ja) 2002-05-14
BR9910176A (pt) 2001-01-09
GB9809350D0 (en) 1998-07-01
NO20005498D0 (no) 2000-11-01
CN1308629A (zh) 2001-08-15
EP1084118A1 (en) 2001-03-21
KR20010043216A (ko) 2001-05-25
AU3719699A (en) 1999-11-23
PL343705A1 (en) 2001-08-27

Similar Documents

Publication Publication Date Title
US6022869A (en) Aminoheterocyclic compounds with antithrombotic/anticoagulant effect
EP1477175B1 (en) Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
AU754747B2 (en) Heterocyclic derivatives which inhibit factor XA
TWI232105B (en) Novel compounds and their preparation process and pharmaceutical formulation containing the same
BG102948A (bg) Пиразинони като инхибитори на тромбин
EP2138482A1 (en) Bicyclic heterocyclic compound
JP2002525370A (ja) トロンビン阻害剤
US6326386B1 (en) Benzamide derivatives as thrombin inhibitors
JP2002513782A (ja) Xa因子を阻害する複素環誘導体
EP1015449B1 (en) (hetero)aryl-sulfonamide derivatives, their preparation and their use as factor xa inhibitors
CA2331041A1 (en) Reduced particle size form of 1-(6-chloronaphth-2-ylsulphonyl)-4-¬4-(4pyridyl)benzoyl|piperazine
EP1150974B1 (en) Heterocyclic derivatives as inhibitors of factor xa
WO2001017990A1 (en) Heterocyclic derivatives as inhibitors of factor xa
MXPA00010676A (en) Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) -4-[4-(4pyridyl) benzoyl]piperazine
EP1117644A1 (en) Benzamide derivatives as thrombin inhibitors
CZ20004037A3 (cs) Forma l-(6-chlornaft-2-ylsulfonyl)-4-[4-(4- pyridyl)benzoyl]piperazinu se zmenšenu velikostí částic a farmaceutická kompozice tuto formu obsahující
WO2000078749A1 (en) Sulfonamide derivative as factor xa inhibitor
MXPA01008067A (es) Derivados heterociclicos como inhibidores del factor xa
MXPA00000505A (en) Heterocyclic derivatives which inhibit factor xa
JP2000503634A (ja) トロンビン阻害剤としてのベンズアミド誘導体

Legal Events

Date Code Title Description
FZDE Discontinued